In Vitro Activity of Daclatasvir on Hepatitis C Virus Genotype 3 NS5A

The NS5A replication complex inhibitor daclatasvir (DCV; BMS-790052) inhibits hybrid replicons containing hepatitis C virus (HCV) genotype 3a (HCV3a) NS5A genes with 50% effective concentrations (EC(50)s) ranging from 120 to 870 pM. Selection studies with a hybrid HCV3a replicon identified NS5A resi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wang, Chunfu, Valera, Lourdes, Jia, Lingling, Kirk, Melissa J., Gao, Min, Fridell, Robert A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2013
Konular:
Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535966/
https://ncbi.nlm.nih.gov/pubmed/23089758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01874-12
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller